First Report Customer Care 
All time: 4.6

Latest / Last 30 Days: 5.0

526 Reviews

Credit Rating - EAGLE PHARMACEUTICALS LIMITED

ANALYSIS
Credit Risk Update: ACCOUNTS DUE FLAG: EAGLE PHARMACEUTICALS LIMITED, 6 Ketterer Court, St Helens, Merseyside, WA9 3AH. The legal status is a Private Limited Company and the current status at the registry of companies is Dissolved. The last filed accounts are dated 30 June 2016. The company was incorporated on 14 October 2002.

The accounts next due date is 31 March 2018. There are no mortgages.

The above was based on public record information as at 28 September 2024 and may not reflect the current status. Please access the current report to ascertain the current status and credit rating.
SUMMARY
Registered Number: 04561464
Date Incorporated: 14 October 2002
Date Latest Accounts: 30 June 2016
BUSINESS INFORMATION
Legal Form: Private Limited Company
Previous Names: None
Registered Number: 04561464
Annual Return: 11 October 2015
Registered Office: 6 Ketterer Court, St Helens, Merseyside, WA9 3AH
SIC Code and Operations: 74990
SECURED CREDITORS
Number of Mortgages 0
Satisfied Mortgages 0
Part Satisfied Mortgages 0
Unsatisfied Mortgages 0
CREDIT RISK RATING
This is the credit risk assessment used by one of the top UK credit reference agencies.
Risk Score (1-100):

EAGLE PHARMACEUTICALS LIMITED

Click Here

to view this information

Risk Assessment:
Credit Rating:



First Report Score: (0-10):

Financial Status Guide:
10  trafficlight Very Strong
9   Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical
Report Created On 8 October 2024 Copyright © 2024 First Report Ltd


Recent Searches

Reg No. Reg Name Status
FC017528 EAGLE PHOENIX PROPERTIES INVESTMENTS LIMITED Active
14407855 EAGLE PHOENIX PROPERTY INVESTMENTS LTD Active
05455407 EAGLE PHOTOGRAPHIC LIMITED Dissolved
05562475 EAGLE PICTURE LIBRARY LIMITED Active
08143736 EAGLE PILOT SERVICES LTD Active - Proposal to Strike off

In using this service you agree to the Terms and Conditions

© 2024 First Report Ltd